Effects of Fruit Consumption on Risk Factors of Chronic Disease
A Randomized Controlled, Crossover in Design, Double Blind Clinical Trial Investigating the Effects of Whole Versus Processed Fruit Consumption on Risk Factors for Chronic Disease and Performance Indicators.
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Undersøgelsestype
Undersøgelsestype
Tilmelding (Faktiske)
Tilmelding
Fase
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Berkshire
-
Reading, Berkshire, Det Forenede Kongerige, RG2 9AR
- University of Reading
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Males due to potential hormonal fluctuations in female subjects
- Aged 30-65years
- Fasting total cholesterol in the upper half of the normal range (6.0-8.0 mmol/l) or triacylglycerol >0.8 mmol/l or a BMI 25-32 kg/m2.
- Not having suffered a myocardial infarction/stroke in the past 12 months
- Not diabetic (diagnosed or fasting glucose > 7 mmol/l) or suffer from other endocrine disorders
- Not suffering from renal or bowel disease or have a history of choleostatic liver or pancreatitis
- Not on drug treatment for hyperlipidaemia, hypertension, inflammation or hypercoagulation
- No history of alcohol misuse
- Not planning or on a weight reducing regime
- Not taking any fish oil, fatty acid or vitamin and mineral supplements
- Non smokers
- Not suffering from depression as indicated by the Brief Symptom Inventory (Appendix 11).
- Not suffering from mild cognitive impairment or dementia according to the MMSE (score ≥ 25).
Exclusion Criteria:
- Females
Medication for hypertension, hyperlipidaemia, inflammation or hypercoagulation
- Hypertension - ACE Inhibitors (e.g. Captopril, Cilazapril), Angiotensin Receptor Blockers (Valsartan), Calcium Channel Blockers (Amlodipine, Nicardipine), Diuretics (Chlortalidone) or Beta blockers (Sotalol, Bisoprolol).
- Cholesterol lowering (Pravastatin, Simuvustatin)
- Anticoagulants (Warfarin)
- Inflammation - NSAID's (Tiaprofenic acid, Sulindac, Ibuprofen), Corticosteroids(Betamethasone)
- Strict vegetarians
- Smokers
- Those on or planning a weight reducing regime
- Blood glucose, haemaglobin or liver enzymes outside of the normal range
- Unable to consume study meals
- Those suffering from depression as indicated by the Brief Symptom Inventory (Appendix 11).
- Those suffering from mild cognitive impairment or dementia as indicated by the MMSE (score < 25).
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Grundvidenskab
- Tildeling: Randomiseret
- Interventionel model: Crossover opgave
- Maskning: Firedobbelt
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Placebo komparator: Control
macro- and micro-nutrient matched control (240 ml)
|
|
|
Eksperimentel: Orange juice
commercial orange juice (240 ml)
|
|
|
Eksperimentel: whole orange
whole orange fruit (240 ml)
|
|
|
Eksperimentel: processed whole orange
processed whole orange (240 ml)
|
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Flow mediated dilation
Tidsramme: change in Flow Mediated Dilation response between baseline and 6 hours
|
change in Flow Mediated Dilation response between baseline and 6 hours
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Postprandial plasma glucose
Tidsramme: change in glucose from baseline to 2 hours
|
change in glucose from baseline to 2 hours
|
|
Postprandial insulin
Tidsramme: change from baseline to 2 hours
|
change from baseline to 2 hours
|
|
global cognitive function
Tidsramme: change from baseline to 6 hours
|
change from baseline to 6 hours
|
|
Blood pressure
Tidsramme: change from baseline to 6 hours
|
change from baseline to 6 hours
|
|
postprandial non-esterified fatty acids
Tidsramme: change from baseline to 6 hours
|
change from baseline to 6 hours
|
|
Postprandial triacylglycerol
Tidsramme: change from baseline to 6 hours
|
change from baseline to 6 hours
|
|
total HDL/LDL
Tidsramme: change from baseline to 6 hours
|
change from baseline to 6 hours
|
|
Inflammatory status (IL1-beta; IL2; IL6; IL10; IFN-gamma; TNF-alpha; CRP)
Tidsramme: change from baseline to 6 hours
|
change from baseline to 6 hours
|
|
LDL oxidation
Tidsramme: change from baseline to 6h
|
change from baseline to 6h
|
Andre resultatmål
Andre resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Plasma flavanone metabolites
Tidsramme: change from baseline to 6 hours
|
change from baseline to 6 hours
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Samarbejdspartnere
Samarbejdspartnere
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart
Studiestart
Primær færdiggørelse (Faktiske)
Primær færdiggørelse
Studieafslutning (Faktiske)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- UOR-0001
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .